Ameriprise Financial Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

Ameriprise Financial Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.53 $2,674 - $6,750	-12,737 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.32 - $0.67 $5,760 - $12,060	-18,000 Reduced 58.56%	12,737 $7,000
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $9,766 - $18,068	16,278 Added 112.58%	30,737 $19,000
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.82 $424 - $764	-420 Reduced 2.82%	14,459 $15,000
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $938 - $1,491	-675 Reduced 4.34%	14,879 $27,000
Q1 2021 May 17, 2021	SELL	$1.27 - $3.42 $2,134 - $5,749	-1,681 Reduced 9.75%	15,554 $31,000
Q4 2020 Feb 12, 2021	SELL	$0.94 - $1.89 $31,691 - $63,719	-33,714 Reduced 66.17%	17,235 $21,000
Q3 2020 Nov 16, 2020	BUY	$1.5 - $9.38 $7,273 - $45,483	4,849 Added 10.52%	50,949 $91,000
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $220,819 - $386,779	46,100 New	46,100 $387,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.